Ergotrate Side Effects
Generic name: ergonovine
Medically reviewed by Drugs.com. Last updated on Jan 14, 2024.
Note: This document provides detailed information about Ergotrate.
Applies to ergonovine: compounding powder, injectable solution, oral tablet Side Effects associated with ergonovine. Some dosage forms listed on this page may not apply specifically to the brand name Ergotrate.
Applies to ergonovine: compounding powder, injectable solution, oral tablet.
General
Administration of correct dose to carefully selected patients who are closely monitored, yields little risk of serious adverse systemic effects; however, IV administration may produce serious adverse effects if the injections are not diluted and administered slowly.[Ref]
Cardiovascular
- Frequency not reported: Gangrene, coronary artery vasospasm, peripheral vasospasm, hypotension, hypertension, thrombophlebitis, myocardial infarction (single case report), ventricular arrhythmias, transient chest pain, palpitation, bradycardia, vasoconstriction
Gastrointestinal
- Very rare (less than 0.01%): Mesenteric ischemia and large bowel infarction (single case report)
- Frequency not reported: Abdominal pain, diarrhea, nausea, esophageal spasm, vomiting, unpleasant taste
Hypersensitivity
- Frequency not reported: Allergic phenomena (including shock, hypertension, chest pain, palpitation, dyspnea, and bradycardia), anaphylactic/anaphylactoid reaction
Nervous system
- Frequency not reported: Dizziness, headache
Metabolic
- Frequency not reported: Clinical exacerbations of porphyria, water intoxication
Dermatologic
- Frequency not reported: Sweating, diaphoresis, skin rashes
Respiratory
- Frequency not reported: Dyspnea, nasal congestion, pulmonary edema, pleural thickening
Musculoskeletal
- Very rare (less than 0.01%): Unmasking of myasthenia gravis (single case report)
- Frequency not reported: Leg cramps
- Postmarketing reports: Muscle spasm
Ocular
- Postmarketing reports: Eye movement disorder
Psychiatric
- Frequency not reported: Hallucinations
Genitourinary
- Frequency not reported: Hematuria
Hepatic
- Frequency not reported: Abnormal liver function test
Other
Renal
- Postmarketing reports: Increased blood creatine
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. (2015) "Canadian Product Information."
More about Ergotrate (ergonovine)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: uterotonic agents
- Breastfeeding
Related treatment guides
Further information
Ergotrate side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.